Wednesday, 05 Nov 2025

MedPulse360

Pharmaceutical

Updated Daily
366 Articles

Lilly to submit obesity pill after hitting goal in third late-stage trial
14 September, 2025

Anne White to retire as head of Lilly Neuroscience after three decades at company
14 September, 2025

Novartis blood disorder drug shows promise in late-stage trial
14 September, 2025

<a href="https://www.fiercepharma.com/pharma/beone-bags-885m-royalty-deal-amgen-lung-cancer-drug-imdelltra" hreflang="en">BeOne bags $885M upfront in Royalty deal on Amgen's lung cancer drug Imdelltra</a>
14 September, 2025

<a href="https://www.fiercepharma.com/pharma/fda-rolls-out-daily-updates-adverse-event-dashboard-plans-further-streamline-system" hreflang="en">FDA rolls out daily updates to adverse event dashboard, plans to further 'streamline' system</a>
14 September, 2025

<a href="https://www.fiercepharma.com/pharma/fda-does-180-suspending-use-valnevas-chikungunya-vaccine" hreflang="en">FDA does a 180, suspending use of Valneva's chikungunya vaccine</a>
14 September, 2025

<a href="https://www.fiercepharma.com/pharma/mannkind-grabs-scpharmaceuticals-and-its-heart-failure-infuser-furoscix-360m-deal" hreflang="en">MannKind grabs scPharmaceuticals and its heart failure infuser Furoscix in $360M deal</a>
14 September, 2025

<a href="https://www.fiercepharma.com/pharma/late-stage-trial-win-argenx-preps-fda-filing-push-vyvgart-broader-myasthenia-gravis" hreflang="en">With late-stage trial win, Argenx preps FDA filing to push Vyvgart into broader myasthenia gravis...
14 September, 2025

Drugs from China are reshaping biotech. Track the licensing deals here.
14 September, 2025

AbbVie wagers more than $1B on Gilgamesh’s psychedelic drug
14 September, 2025
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago